HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charles Butts Selected Research

L-BLP25

1/2014Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.
8/2007L-BLP25: a peptide vaccine strategy in non small cell lung cancer.
6/2005Vaccination with BLP25 liposome vaccine to treat non-small cell lung and prostate cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Charles Butts Research Topics

Disease

24Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 12/2004
11Neoplasms (Cancer)
04/2019 - 06/2005
5Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2012 - 06/2006
3Disease Progression
01/2021 - 06/2004
3Neutropenia
12/2017 - 06/2004
3Neoplasm Metastasis (Metastasis)
01/2014 - 07/2004
3Colorectal Neoplasms (Colorectal Cancer)
03/2008 - 06/2004
2Fatigue
10/2019 - 06/2005
2Vomiting
12/2012 - 06/2005
2Constipation
12/2012 - 06/2005
2Adenocarcinoma
06/2005 - 07/2004
1Cachexia
04/2019
1Hypertension (High Blood Pressure)
12/2017
1Breast Neoplasms (Breast Cancer)
03/2015
1Lung Neoplasms (Lung Cancer)
01/2014
1Pneumonia (Pneumonitis)
01/2014
1Diarrhea
12/2012
1Dyspnea (Shortness of Breath)
12/2012
1Alopecia (Baldness)
12/2012
1Pain (Aches)
12/2012
1Frailty
04/2011
1Small Cell Carcinoma
07/2010
1Exanthema (Rash)
09/2007
1Febrile Neutropenia
06/2005
1Anorexia
06/2005
1Nausea
06/2005
1Prostatic Neoplasms (Prostate Cancer)
06/2005
1Colonic Neoplasms (Colon Cancer)
06/2004

Drug/Important Bio-Agent (IBA)

5Cisplatin (Platino)FDA LinkGeneric
12/2012 - 06/2005
4Erlotinib Hydrochloride (CP 358,774)FDA Link
08/2017 - 07/2008
4Liposomes (Liposome)IBA
09/2011 - 06/2005
4VaccinesIBA
09/2011 - 06/2005
3Carboplatin (JM8)FDA LinkGeneric
10/2019 - 07/2015
3L-BLP25IBA
01/2014 - 06/2005
3AntigensIBA
01/2014 - 06/2005
3GemcitabineFDA Link
12/2012 - 07/2008
2NivolumabIBA
01/2021 - 10/2019
2Docetaxel (Taxotere)FDA Link
01/2021 - 10/2019
2Biomarkers (Surrogate Marker)IBA
10/2019 - 08/2017
2Cancer VaccinesIBA
11/2010 - 06/2005
2Irinotecan (Camptosar)FDA LinkGeneric
05/2009 - 07/2004
2Fluorouracil (Carac)FDA LinkGeneric
05/2009 - 07/2004
2Leucovorin (Folinic Acid)FDA Link
05/2009 - 07/2004
2Vinorelbine (Navelbine)FDA LinkGeneric
02/2007 - 06/2005
1AZD 6244IBA
01/2019
1Pemetrexed (MTA)FDA Link
01/2019
1PlatinumIBA
01/2019
1Bevacizumab (Avastin)FDA Link
12/2017
1CreatinineIBA
07/2015
1LipopeptidesIBA
01/2014
1ErbB Receptors (EGF Receptor)IBA
09/2013
1Gefitinib (Iressa)FDA Link
09/2013
1Biological ProductsIBA
07/2008
1Carcinoembryonic AntigenIBA
03/2008
1Epidermal Growth Factor (EGF)IBA
09/2007
1vandetanib (ZD6474)IBA
09/2007
1Protein Subunit VaccinesIBA
08/2007
1Glycoproteins (Glycoprotein)IBA
08/2007
1TubulinIBA
02/2007
1Peptides (Polypeptides)IBA
06/2005
1Prostate-Specific Antigen (Semenogelase)IBA
06/2005
1Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2004
1thiamine triphosphorate (TTP)IBA
06/2004
1XELOXIBA
06/2004
1Capecitabine (Xeloda)FDA Link
06/2004

Therapy/Procedure

16Drug Therapy (Chemotherapy)
10/2019 - 06/2005
7Therapeutics
10/2019 - 06/2004
6Adjuvant Chemotherapy
12/2017 - 07/2004
6Radiotherapy
06/2017 - 12/2004
2Immunotherapy
01/2021 - 01/2014
2Chemoradiotherapy
01/2014 - 08/2007
2Induction Chemotherapy
09/2007 - 12/2004
1Injections
01/2014
1Consolidation Chemotherapy
02/2012
1Prostatectomy (Retropubic Prostatectomy)
06/2005
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
12/2004
1Cryosurgery
07/2004
1Radiofrequency Ablation
07/2004
1Neoadjuvant Therapy
07/2004